Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

47201 - 47210 of 57753 results found

Furin as a therapeutic target in cystic fibrosis airways disease

Date
Wednesday, May 03, 2023 - 4:00 AM
Description
Clinical management of cystic fibrosis (CF) has been greatly improved by the development of small molecule modulators of the CF transmembrane conductance regulator (CFTR). These drugs help to address some of the basic genetic defects of CFTR; however

Nonpharmaceutical Interventions in Georgia: Public Health Implications

Date
Wednesday, May 03, 2023 - 4:00 AM
Description
CONCLUSIONS: Our findings indicate that protecting vulnerable populations, implementing social distancing, and mandating masks may be effective countermeasures to containment while mitigating the economic and psychosocial effects of strict shelters

OPTN/SRTR 2021 Annual Data Report: Liver

Date
Wednesday, May 03, 2023 - 4:00 AM
Description
In 2021, liver transplant volume continued to grow, with a record 9,234 transplants performed in the United States, 8,665 (93.8%) from deceased donors and 569 (6.2%) from living donors. There were 8,733 (94.6%) adult and 501 (5.4%) pediatric liver

Telerehabilitation in pulmonary diseases

Date
Wednesday, May 03, 2023 - 4:00 AM
Description
PURPOSE OF REVIEW: Telerehabilitation is an alternative delivery model for pulmonary rehabilitation, an evidence-based nonpharmacological intervention, in people with chronic pulmonary disease. This review synthesizes current evidence regarding the

Polysubstance use and its correlation with psychosocial and health risk behaviours among more than 95,000 Norwegian adolescents during the COVID-19 pandemic (January to May 2021): a latent profile analysis

Date
Wednesday, May 03, 2023 - 4:00 AM
Description
BACKGROUND: Polysubstance use represents an adolescent health risk; however, large-scale studies investigating this issue during the COVID-19 pandemic are scarce. We aim to (i) characterise substance use profiles among adolescents and (ii) identify